Login to Your Account

Pharma: Other News To Note

Thursday, August 16, 2012
• Renaissance Pharma Inc., of Newtown, Pa., acquired the U.S. rights to manufacture, market and sell Denavir (1 percent penciclovir cream) from investment funds managed by Deerfield Management Co. and New American Therapeutics Inc., of Cranford, N.J.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription